We backed Zymvol because enzymes have the potential to transform manufacturing, but discovering the right catalyst has historically been a costly process of trial and error. Zymvol replaces experimentation with predictive computational design, enabling companies to rapidly engineer high-performance biocatalysts that reduce development time, improve economics and make green chemistry commercially viable at industrial scale.